Lipocine Inc.
- LPCN
- NASDAQ
- Biotechnology
- Neuroendocrine/Metabolic Drugs
- Oral Drug Delivery
$1.56
Today −7.14%Quote Oct 16, 2026, 08:00 PM UTC
−29.73%over the last month
Max drawdown −30.4%From 1-month high −30.4%3 months −27.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$12.9M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$4.00
+156.4% from here
Floor
$1.24
20.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LPCNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14